Related Experiment Video

Updated: May 20, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Primary progressive multiple sclerosis

Kathleen Hawker

    Continuum (Minneapolis, Minn.)
    |July 20, 2012
    PubMed

    Insights

    Primary progressive multiple sclerosis (PPMS) presents a diagnostic challenge due to its insidious progression. Understanding PPMS pathogenesis offers insights into multiple sclerosis progression overall.

    Area of Science:

    • Neurology
    • Neuroimmunology
    • Clinical Neuroscience

    Background:

    • Primary progressive multiple sclerosis (PPMS) accounts for 10-15% of all multiple sclerosis cases.
    • PPMS is characterized by insidious disease progression from onset, distinguishing it from relapsing-remitting MS.
    • Diagnosis of PPMS can be challenging, frequently leading to misdiagnosis and delayed treatment initiation.

    Purpose of the Study:

    • To highlight the diagnostic difficulties associated with primary progressive multiple sclerosis.
    • To underscore the importance of understanding the pathogenesis of PPMS.
    • To elucidate how insights into PPMS can inform the broader understanding of multiple sclerosis progression.

    Main Methods:

    • Review of clinical characteristics differentiating PPMS from other MS forms.
    • Analysis of diagnostic challenges and common pitfalls.
    • Examination of current understanding of PPMS pathogenesis.

    Main Results:

    • PPMS exhibits a distinct, gradual progression pattern from disease onset.
    • Diagnostic delays and misdiagnoses are prevalent in PPMS cases.
    • Pathogenic insights into PPMS are crucial for understanding disease progression across all multiple sclerosis phenotypes.

    Conclusions:

    • Despite the absence of effective treatments, understanding PPMS pathogenesis is vital.
    • Insights gained from studying PPMS contribute to a comprehensive understanding of multiple sclerosis.
    • Accurate and timely diagnosis of PPMS remains a significant clinical challenge.

    More Related Videos

    Comprehensive Autopsy Program for Individuals with Multiple Sclerosis09:41

    Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

    Published on: July 19, 2019

    Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis08:11

    Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

    Published on: November 14, 2016

    Related Concept Videos

    Multiple Sclerosis l: Introduction01:19

    Multiple Sclerosis l: Introduction

    Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
    Parkinson's Disease: Overview01:15

    Parkinson's Disease: Overview

    Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
    Myasthenia Gravis ll: Pathophysiology01:22

    Myasthenia Gravis ll: Pathophysiology

    The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
    Alzheimer Disease l: Introduction01:29

    Alzheimer Disease l: Introduction

    Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
    Tumor Progression02:07

    Tumor Progression

    Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
    Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
    Parkinson Disease ll: Pathophysiology01:24

    Parkinson Disease ll: Pathophysiology

    Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...